Summary
Boston Scientific Corporation (BSX) filed an 8-K on December 10, 2004, detailing its executive and director compensation programs. The filing primarily serves to provide investors with the standardized forms of various equity awards and incentive plans used by the company. This includes forms for Non-Qualified Stock Options, Restricted Stock Awards, and Deferred Stock Units, applicable to both executive officers/key employees and non-employee directors. Additionally, the report outlines the structure of the company's Performance Incentive Plan, which offers annual cash bonuses to salaried personnel, including executive officers. Performance metrics for these bonuses are tied to quarterly company and individual objectives, focusing on sales and profitability goals. This filing provides transparency into how the company incentivizes its leadership and key personnel, aligning their interests with corporate performance.
Key Highlights
- 1Boston Scientific is formalizing its executive and director compensation structure by filing standard award agreements.
- 2The company utilizes Non-Qualified Stock Options, Restricted Stock, and Deferred Stock Units as key components of its incentive plans.
- 3Equity awards are offered to both executive officers/key employees and non-employee directors.
- 4Performance Incentive Plan provides annual cash bonuses based on quarterly company and individual performance objectives.
- 5Performance metrics for cash bonuses include revenue and net income goals.
- 6The filing attaches forms of grant agreements for various award types and the Performance Incentive Plan as exhibits.